biological source
mouse
Quality Level
antibody form
purified antibody
antibody product type
primary antibodies
clone
9E10, monoclonal
form
liquid
contains
≤0.1% sodium azide as preservative
species reactivity
rat (weakly), human, mouse (weakly)
manufacturer/tradename
Calbiochem®
storage condition
do not freeze
dilution
(Flow Cytometry (20 µg/mL)
Frozen Sections (2-10 µg/mL)
Immunoblotting (1-5 µg/mL,
Immunofluorescence (1-5 µg/mL)
Immunoprecipitation (1 µg/sample)
Chromatin Immunoprecipitation (5 µg/mL,
Paraffin Sections (not recommended))
isotype
IgG1
shipped in
wet ice
storage temp.
2-8°C
target post-translational modification
unmodified
Gene Information
human ... MYC(4609)
mouse ... Myc(17869)
rat ... Myc(24577)
General description
Purified mouse monoclonal antibody generated by immunizing BALB/c mice with the specified immunogen and fusing splenocytes with SP2/0 mouse myeloma cells. Recognizes the ~64-67 kDa (apparent MW) c-Myc protein.
Recognizes the ~60-67 kDa c-Myc protein in HL60 cells and lung carcinoma tissue.
This Anti-c-Myc (Ab-1) Mouse mAb (9E10) is validated for use in FC, Frozen Sections, Immunoblotting, IF, IP, Chromatin IP, Paraffin Sections for the detection of c-Myc (Ab-1).
Immunogen
Human
a synthetic peptide (AEEQKLISEEDLLRKRREQLKHKLEQLRNSCA) corresponding to amino acids 408-439 of human c-Myc
Epitope: within amino acids 410-419
Application
Flow Cytometry (20 µg/ml or use Cat. No. OP10F)
Frozen Sections (2-10 µg/ml)
Immunoblotting (1-5 µg/ml, see application references)
Immunofluorescence (1-5 µg/ml or use Cat. No. OP10F)
Immunoprecipitation (1 µg/sample)
Chromatin Immunoprecipitation (5 µg/ml, see application references)
Paraffin Sections (not recommended)
Frozen Sections (2-10 µg/ml)
Immunoblotting (1-5 µg/ml, see application references)
Immunofluorescence (1-5 µg/ml or use Cat. No. OP10F)
Immunoprecipitation (1 µg/sample)
Chromatin Immunoprecipitation (5 µg/ml, see application references)
Paraffin Sections (not recommended)
Packaging
Please refer to vial label for lot-specific concentration.
Physical form
In 0.05 M sodium phosphate buffer, 0.2% gelatin.
Analysis Note
Negative Control
HT1080 cells
HT1080 cells
Positive Control
HL-60 cells or lung carcinoma
HL-60 cells or lung carcinoma
Other Notes
LeGouy, E., et al. 1987. In Nuclear Oncogenes, Cold Spring Harbor Laboratory, 144.
Cole, M.D. 1986. Ann. Rev. Gen.20, 361.
Nisen, P.D., et al. 1986. Cancer Res.46, 6217.
Nau, M.M., et al. 1985. Nature318, 69.
Persson, H., et al. 1984. Science225, 687.
Alitalo, K., et al. 1983. Proc. Natl. Acad. Sci. USA80, 1707.
Cole, M.D. 1986. Ann. Rev. Gen.20, 361.
Nisen, P.D., et al. 1986. Cancer Res.46, 6217.
Nau, M.M., et al. 1985. Nature318, 69.
Persson, H., et al. 1984. Science225, 687.
Alitalo, K., et al. 1983. Proc. Natl. Acad. Sci. USA80, 1707.
The c-Myc protein is extremely labile. c-Myc degradation can be as a result of freeze/thaw cycles, thus, we recommend using fresh lysates with a cocktail of protease inhibitors. c-Myc is often destroyed during the processing of paraffin sections and can therefore be difficult to detect in this application. This antibody recognizes the c-Myc protein and its cleavage products. The sequence of c-Myc predicts a 45 kDa protein, but c-Myc migrates under reducing conditions as a 64-67 kDa band. This antibody will not detect v-Myc but may react weakly to rodent c-Myc when used at high concentrations (10 µg/ml). An extra 34-40 kDa band may be detected in a immunoblot. May also be used in immunofluorescence as well as the detection and purification of recombinant proteins tagged with the Myc epitope sequence EQKLISEEDL (see application references). The immunogen, c-Myc (Peptide-1) is also available for competition studies (Cat. No. PP06). Antibody should be titrated for optimal results in individual systems.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
Still not finding the right product?
存储类别
10 - Combustible liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Lixia Pu et al.
The Journal of biological chemistry, 277(49), 46877-46885 (2002-10-03)
The Cdc25 dual specificity phosphatases coordinate cell cycle progression, but potent and selective inhibitors have generally been unavailable. In the present study, we have examined one potential inhibitor, 6-chloro-7-(2-morpholin-4-ylethylamino)-quinoline-5,8-dione (NSC 663284), that was identified in the compound library of the
E Mata-Greenwood et al.
Leukemia, 16(11), 2275-2284 (2002-10-26)
Employing the natural product quassinoid brusatol, we currently report cellular and molecular events leading to cell death or terminal differentiation in a panel of leukemic cells. Brusatol and bruceantin exerted significant cytotoxic effects with several leukemic cell lines, but not
Deyu Tarika Cai et al.
Molecular membrane biology, 28(2), 90-102 (2011-01-15)
Since being introduced globally as Aspirin in 1899, acetylsalicylic acid (ASA) has been widely used as an analgesic, immune-regulatory, anti-pyretic and anti-thrombotic drug. ASA and its metabolite, salicylate, were also reported to be able to modulate antigen presenting functions of
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| OP10-200UG | 04055977224900 |